Merck (MRK)

75.21 -0.68 (0.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/5/21 *Est.)
- M&A (6/30/19 *Est)

Latest Headlines

Merck CEO Doesn't See Therapeutics or Vaccines 'as a Silver Bullet', Believes Mask-Wearing Will Stay 'Well Into 2021' October 29, 2020 9:13 AM - StreetInsider Next crop of COVID-19 vaccine developers take more traditional route October 29, 2020 12:10 AM - StreetInsider GSK warns COVID-19 will dent full-year earnings October 28, 2020 8:11 AM - StreetInsider Form 8-K Merck & Co., Inc. For: Oct 27 October 27, 2020 6:51 AM - SEC Filing Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook October 27, 2020 6:49 AM - StreetInsider Merck Announces Third-Quarter 2020 Financial Results October 27, 2020 6:45 AM - BizWire Options expected to have increasing volume: JBLU HA PFE MRK HOG LLY October 27, 2020 4:44 AM - StreetInsider Merck (MRK) call put ratio 4.1 calls to 1 put with focus on October weekly calls into quarter results and outlook October 26, 2020 10:54 AM - StreetInsider Truist Securities Reinstates Merck (MRK) at Buy October 22, 2020 4:09 PM - StreetInsider Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts October 22, 2020 8:00 AM - BizWire Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020 October 21, 2020 6:45 AM - BizWire Merck (MRK) Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Investigational 15-valent Pneumococcal Conjugate Vaccine October 20, 2020 6:45 AM - StreetInsider Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine October 20, 2020 6:45 AM - BizWire U.S., Britain call out Russian hacking spree, cyberattacks against Olympics October 19, 2020 1:08 PM - StreetInsider Merck Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy and Updated Phase 1/2 Data for Investigational Quavonlimab (MK-1308) in Combination With KEYTRUD October 16, 2020 2:00 PM - BizWire Trump admin to announce vaccine deal for seniors - Politico October 16, 2020 12:48 PM - StreetInsider Merck (MRK) PT Raised to $105 at JPMorgan October 16, 2020 4:32 AM - StreetInsider Merck (MRK) Announces FDA Approves Expanded Indication for KEYTRUDA in Adult Patients With R/R Classical Hodgkin Lymphoma October 15, 2020 6:46 AM - StreetInsider FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) in Adult Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) October 15, 2020 6:45 AM - BizWire Merck Issues 2019/2020 Corporate Responsibility Report October 14, 2020 8:00 AM - BizWire As U.S. politics heats up, companies seek to avoid controversy October 13, 2020 8:03 AM - StreetInsider Johnson & Johnson (JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness October 12, 2020 10:20 PM - StreetInsider MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant October 8, 2020 8:30 AM - PR NewsWire Merck (MRK) Announces Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination With Doravirine in Adults With HIV-1 Infection October 8, 2020 6:50 AM - StreetInsider Moderna (MRNA) has regained all rights to respiratory syncytial virus vaccine (mRNA-1172) from Merck (MRK) October 8, 2020 6:46 AM - StreetInsider Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination With Doravirine in Adults With HIV-1 Infection October 8, 2020 6:45 AM - BizWire Investors eye discounted U.S. healthcare sector as Biden's lead in polls grows October 8, 2020 1:04 AM - StreetInsider Form 4 Merck & Co., Inc. For: Oct 05 Filed by: Davis Robert M October 6, 2020 4:52 PM - SEC Filing MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant October 6, 2020 1:00 PM - PR NewsWire Bristol Myers expands heart drug business with $13 billion deal for MyoKardia October 5, 2020 6:40 AM - StreetInsider Form 4 Merck & Co., Inc. For: Sep 30 Filed by: Seidman Christine E October 2, 2020 5:24 PM - SEC Filing Form 4 Merck & Co., Inc. For: Sep 30 Filed by: WENDELL PETER C October 2, 2020 5:21 PM - SEC Filing Form 4 Merck & Co., Inc. For: Sep 30 Filed by: Coe Mary Ellen October 2, 2020 5:07 PM - SEC Filing Covid-19 vaccines: Efficacy results likely in November - Morgan Stanley October 2, 2020 8:48 AM - StreetInsider Merck (MRK) Announces Retirement of Dr. Roger M. Perlmutter; Dr. Dean Y. Li Appointed as President, Merck Research Laboratories October 2, 2020 8:06 AM - StreetInsider Merck Announces Retirement of Dr. Roger M. Perlmutter; Dr. Dean Y. Li Appointed as President, Merck Research Laboratories October 2, 2020 8:00 AM - BizWire Vaccine stocks on watch after President Trump tests positive for COVID-19 October 2, 2020 7:05 AM - StreetInsider Merck to Present New Data from the Company’s Diverse HIV Portfolio and Pipeline at HIV Glasgow 2020 October 1, 2020 6:45 AM - BizWire Merck to Hold Third-Quarter 2020 Sales and Earnings Conference Call on October 27 October 1, 2020 6:30 AM - BizWire Regeneron Monoclonal Antibody Data Increases Probability Of COVID-19 Vaccine Success - Morgan Stanley September 30, 2020 8:46 AM - StreetInsider Berenberg Starts Merck (MRK) at Hold September 29, 2020 1:20 AM - StreetInsider Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day September 28, 2020 6:45 AM - BizWire ALX Oncology (ALXO) Announces Collaboration with Merck (MRK) on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination with KEYTRUDA (pembrolizumab) September 22, 2020 7:04 AM - StreetInsider Seattle Genetics (SGEN) PT Raised to $165 at Stifel After Considering Merck Contribution September 22, 2020 6:44 AM - StreetInsider Merck's (MRK) KEYTRUDA Plus Chemo Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer September 21, 2020 12:32 PM - StreetInsider Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer September 21, 2020 12:30 PM - BizWire Merck (MRK) Reports First-Line Treatment with KEYTRUDA (pembrolizumab) Doubled 5-Yr Survival Rate (31.9%) vs. Chemotherapy (16.3%) in Certain Patients w/ Metastatic NSCLC & PD-LI Turmors September 21, 2020 8:33 AM - StreetInsider First-Line Treatment With Merck’s KEYTRUDA® (pembrolizumab) Doubled Five-Year Survival Rate (31.9%) Versus Chemotherapy (16.3%) in Certain Patients With Metastatic Non-Small Cell Lung Cancer Whose September 21, 2020 8:25 AM - BizWire AstraZeneca (AZN) and Merck (MRK) Announce LYNPARZA Receives Positive Opinion from EU CHMP for Treatment of BRCA1/2 mCRPC September 21, 2020 6:47 AM - StreetInsider LYNPARZA® (olaparib) Receives Positive Opinion from EU CHMP for Treatment of BRCA1/2 Metastatic Castration-Resistant Prostate Cancer (mCRPC) September 21, 2020 6:45 AM - BizWire LYNPARZA® (olaparib) Recommended for Approval in EU by CHMP as First-Line Maintenance Treatment with Bevacizumab for HRD-Positive Advanced Ovarian Cancer September 21, 2020 6:45 AM - BizWire EU agency recommends AstraZeneca-Merck drug Lynparza for two cancers September 21, 2020 4:21 AM - StreetInsider Merck (MRK) IV flat into oncology presentation September 21, 2020 2:17 AM - StreetInsider LYNPARZA® (olaparib) Reduced the Risk of Death by 31% in BRCA1/2 or ATM-mutated Metastatic Castration-Resistant Prostate Cancer in Phase III Profound Trial September 20, 2020 12:30 PM - BizWire LYNPARZA Reduced Risk of Death by 31% vs. Enzalutamide or Abiraterone for Men with BRCA1/2 or ATM-Mutated Metastatic Castration Resistant Prostate Cancer Who Progressed Following Enzalutamide or Abira September 20, 2020 12:30 PM - BizWire Merck Presents Promising New Data for Three Investigational Medicines From Diverse and Expansive Oncology Pipeline at ESMO Virtual Congress 2020 September 20, 2020 10:20 AM - BizWire Merck and Eisai Present First-Time Data From Two Studies Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020 September 20, 2020 8:25 AM - BizWire Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma September 19, 2020 10:20 AM - BizWire AstraZeneca (AZN), Merck (MRK) Report LYNPARZA Improved Median PFS to Over Four and a Half Years Compared to 13.8 Months with Placebo for Patients with BRCA-Mutated Advanced Ovarian Cancer September 18, 2020 6:46 AM - StreetInsider LYNPARZA® (olaparib) Improved Median Progression-Free Survival to Over Four and a Half Years Compared to 13.8 Months with Placebo for Patients with BRCA-Mutated Advanced Ovarian Cancer September 18, 2020 6:45 AM - BizWire Pfizer (PFE), Merck (MRK) Biopharmaceutical Business, EMD Serono, Reports Publication of BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results September 18, 2020 6:02 AM - StreetInsider BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine September 18, 2020 3:00 AM - PR NewsWire Vaccinex (VCNX) Announces Clinical Collaboration with Merck (MRK) to Evaluate Pepinemab in Combination with KEYTRUDA in Advanced, Recurrent or Metastatic HNSCC September 17, 2020 8:01 AM - StreetInsider Merck to Hold Investor Briefing Following ESMO Virtual Congress 2020 September 16, 2020 6:45 AM - BizWire Trump says not pressing U.S. government for coronavirus vaccine for political reasons September 15, 2020 8:29 AM - StreetInsider Merck to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference September 15, 2020 6:45 AM - BizWire Merck (MRK) option implied volatility flat at 20 September 15, 2020 4:31 AM - StreetInsider Merck (MRK) call put ratio 4.4 calls to 1 put with focus on September calls September 14, 2020 1:36 PM - StreetInsider Merck (MRK), Seattle Genetics (SGEN) announce new collaborations and investment, analysts see positives in them September 14, 2020 10:22 AM - StreetInsider Pre-Open Stock Movers 09/14: (IMMU) (SGMS) (NVDA) Higher; (GILD) (MGM) (WMT) Lower (more...) September 14, 2020 9:30 AM - StreetInsider Seattle Genetics (SGEN) and Merck (MRK) Announce Two Strategic Oncology Collaborations; Merck to Invest $1B September 14, 2020 6:45 AM - StreetInsider Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations September 14, 2020 6:45 AM - BizWire EMD Serono Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020 September 13, 2020 6:05 PM - PR NewsWire /C O R R E C T I O N -- MilliporeSigma/ September 10, 2020 4:01 PM - PR NewsWire Merck to Present at the Morgan Stanley 18th Annual Virtual Global Healthcare Conference September 10, 2020 6:45 AM - BizWire MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion September 9, 2020 9:00 AM - PR NewsWire Merck (MRK) Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Investigational 15-valent Pneumococcal Conjugate Vaccine, Including Pivotal Trial September 9, 2020 6:46 AM - StreetInsider Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine, Including Pivotal Trial September 9, 2020 6:45 AM - BizWire AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares September 9, 2020 4:27 AM - StreetInsider Vaccine stocks on watch as AstraZeneca's (AZN) COVID19 vaccine study put on hold September 8, 2020 5:25 PM - StreetInsider Merck (MRK) PT Raised to $95 at Cowen on Gefapixant Data September 8, 2020 6:59 AM - StreetInsider Merck's (MRK) Gefapixant Significantly Decreased Cough Frequency Compared to Placebo at Week 12 and 24 in Patients with Refractory or Unexplained Chronic Cough September 8, 2020 6:48 AM - StreetInsider Merck’s Gefapixant (45 mg Twice Daily) Significantly Decreased Cough Frequency Compared to Placebo at Week 12 and 24 in Patients with Refractory or Unexplained Chronic Cough September 8, 2020 6:45 AM - BizWire U.S., European COVID-19 vaccine developers pledge to uphold testing rigour September 8, 2020 6:37 AM - StreetInsider Vaccine makers announce pledge, outlining united commitment to uphold integrity of scientific process September 8, 2020 6:31 AM - StreetInsider Biopharma Leaders Unite to Stand with Science September 8, 2020 6:31 AM - StreetInsider Biopharma Leaders Unite to Stand With Science September 8, 2020 6:31 AM - BizWire Biopharma Leaders Unite to Stand with Science September 8, 2020 6:30 AM - Globe NewsWire Biopharma Leaders Unite to Stand with Science September 8, 2020 6:30 AM - BizWire Biopharma Leaders Unite To Stand With Science September 8, 2020 6:30 AM - BizWire Merck to Present at the Citi 15th Annual BioPharma Virtual Conference September 4, 2020 6:45 AM - BizWire EMD Serono to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis September 3, 2020 8:00 AM - PR NewsWire Merck (MRK) Says New Scientific Data at the ESMO Virtual Congress 2020 Reflect its Commitment to Advancing Cancer Research and Care September 2, 2020 6:46 AM - StreetInsider New Scientific Data at the ESMO Virtual Congress 2020 Reflect Merck’s Commitment to Advancing Cancer Research and Care September 2, 2020 6:45 AM - BizWire TriRx Pharmaceutical Services acquires MSD Animal Health manufacturing site located in Segré-en Anjou Bleu, France including long-term supply agreement September 1, 2020 9:00 AM - PR NewsWire Scientists see downsides to top COVID-19 vaccines from Russia, China August 31, 2020 6:10 AM - StreetInsider FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations August 25, 2020 9:00 AM - PR NewsWire Merck (MRK) PT Raised to $97 at Guggenheim August 24, 2020 7:33 AM - StreetInsider Merck's (MRK) KEYTRUDA Receives Two New Approvals in Japan August 24, 2020 6:45 AM - StreetInsider Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan August 24, 2020 6:45 AM - BizWire Popular stocks with increasing volume August 21, 2020 3:28 AM - StreetInsider Merck (MRK) call put ratio 3.9 calls to 1 put with focus on August weekly (28) 87 calls August 20, 2020 12:58 PM - StreetInsider Merck's (MRK) KEYTRUDA in Combination With Chemotherapy Significantly Improved OS and PFS Compared With Chemotherapy in Locally Advanced or First-Line Metastatic Esophageal Cancer August 19, 2020 6:58 AM - StreetInsider Merck’s KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy Significantly Improved Overall Survival and Progression-Free Survival Compared With Chemotherapy in Locally Advanced or First-Line August 19, 2020 6:45 AM - BizWire Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers August 19, 2020 3:23 AM - StreetInsider Form 4 Merck & Co., Inc. For: Aug 13 Filed by: Chattopadhyay Sanat August 17, 2020 6:36 PM - SEC Filing Form 3 Merck & Co., Inc. For: Aug 03 Filed by: Williams David Michael August 13, 2020 4:09 PM - SEC Filing QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma August 13, 2020 3:55 AM - StreetInsider Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020 August 11, 2020 6:30 AM - Globe NewsWire Form 4 Merck & Co., Inc. For: Aug 05 Filed by: Clyburn Frank August 6, 2020 4:54 PM - SEC Filing Form 10-Q Merck & Co., Inc. For: Jun 30 August 5, 2020 8:12 AM - SEC Filing Merck Animal Health Completes Acquisition of IdentiGEN August 5, 2020 7:00 AM - BizWire Merck and Hanmi Pharmaceutical Enter into Licensing Agreement to Develop Efinopegdutide, an Investigational Once-Weekly Therapy for Nonalcoholic Steatohepatitis (NASH) August 4, 2020 5:00 AM - BizWire Merck (MRK) Animal Health Completes Acquisition of Worldwide Rights to VECOXAN Brand of Parasiticides for Ruminant Portfolio August 3, 2020 6:40 AM - StreetInsider Merck Animal Health Completes Acquisition of Worldwide Rights to VECOXAN® Brand of Parasiticides for Ruminant Portfolio August 3, 2020 6:30 AM - BizWire Goldman Sachs Upgrades Merck (MRK) to Buy on Pipeline and Keytruda LOE Priced In August 3, 2020 5:14 AM - StreetInsider Full Article List